JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 14, 2006; DOI: 10.1124/jpet.106.104125


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104125v1
318/1/444    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berson, A.
Right arrow Articles by Pessayre, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berson, A.
Right arrow Articles by Pessayre, D.


Received for publication March 8, 2006.
Revised April 6, 2006.
Accepted for publication April 11, 2006.

The Anti-Inflammatory Drug, Nimesulide Uncouples Mitochondria and Induces Mitochondrial Permeability Transition in Human Hepatoma Cells. Protection by Albumin

Alain Berson 1*, Sophie Cazanave 1, Veronique Descatoire 1, Marina Tinel 1, Alain Grodet 1, Claude Wolf 1, Gerard Feldmann 1, Dominique Pessayre 2

1 INSERM 2 INSERM U773

* Address correspondence to: E-mail: aberson{at}bichat.inserm.fr

Abstract

Like other nonsteroidal anti-inflammatory drugs, nimesulide triggers hepatitis in a few recipients. Although nimesulide has been shown to uncouple mitochondrial respiration and cause hepatocyte necrosis in the absence of albumin, mechanisms for cell death are incompletely understood, and comparisons with human concentrations are difficult because 99% of nimesulide is albumin-bound. We studied the effects of nimesulide, with or without a physiological concentration of albumin, in isolated rat liver mitochondria or microsomes, and in human hepatoma cells. Nimesulide did not undergo monoelectronic nitro reduction in microsomes. In mitochondria incubated without albumin, nimesulide (50 µM) decreased the mitochondrial membrane potential ({Delta}{Psi}m), increased basal respiration, and potentiated the mitochondrial permeability transition (MPT) triggered by calcium preloading. In HUH-7 cells incubated for 24 hours without albumin, nimesulide (1 mM) decreased the {Delta}{Psi}m and cell NAD(P)H, and increased the glutathione disulfide/reduced glutathione ratio and cell peroxides; nimesulide triggered MPT, ATP depletion, high cell calcium, and caused mostly necrosis, with rare apoptotic cells. Co-incubation with either cyclosporin A (an MPT inhibitor) or the combination of fructose-1,6-diphosphate (a glycolysis substrate) and oligomycin (an ATPase inhibitor) prevented the decrease in {Delta}{Psi}m, ATP depletion and cell death. A physiological concentration of albumin abolished the effects of nimesulide on isolated mitochondria or HUH-7 cells. In conclusion, the weak acid, nimesulide uncouples mitochondria and triggers MPT and ATP depletion in isolated mitochondria or hepatoma cells incubated without albumin. However, in the presence of albumin, only a fraction of the drug enters cells or organelles, and uncoupling and toxicity are not observed.


Key words: Hepatitis, Mitochondria, Mitochondrial permeability transition, Nimesulide, Nonsteroidal anti-inflammatory drug, Uncoupling





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.